Treatment of contralateral N0 neck in early squamous cell carcinoma of the oral tongue: elective neck dissection versus observation
- PMID: 16540910
- DOI: 10.1097/01.mlg.0000195366.91395.9b
Treatment of contralateral N0 neck in early squamous cell carcinoma of the oral tongue: elective neck dissection versus observation
Abstract
Objectives/hypothesis: Prophylactic treatment of contralateral N0 neck in early squamous cell carcinoma (SCC) of the oral tongue is a controversial issue. The aim of this study was to analyze the rates of occult metastases and their prognostic effects in stage I and stage II SCC of the oral tongue, and to compare the results of elective neck dissection to observation of the contralateral N0 neck in the treatment of these patients.
Study design: Retrospective review.
Methods: We reviewed the medical records of 54 patients who were treated at Severance Hospital from 1992 to 2003 and had been diagnosed with stage I or stage II SCC of the oral tongue and had not received prior treatment. All patients underwent an ipsilateral elective neck dissection simultaneously with the primary lesion. The management of the contralateral N0 necks involved "watchful waiting" in 29 patients and elective neck dissection in 25 patients. Surgical treatment was followed by radiotherapy in 20 patients. Of these, seven patients belonged to the "observation" group who did not receive contralateral elective neck dissection. The follow-up period ranged from 3 to 110 months, with a mean of 56.3 months. Data were analyzed using the Kaplan-Meier method, the log-rank test, and the chi(2) test.
Results: Fifteen patients (28%, 15 of 54) had occult metastases. Of these, 14 patients (26%, 14 of 54) had ipsilateral pathologic metastases. The remaining case (4%, 1 of 25) had the only contralateral level II occult neck metastasis without ipsilateral metastasis. Disease recurred in 17 of 54 patients (31%). Of these, eight cases (47%, 8 of 17) had regional recurrences. All regional recurrences developed in the ipsilateral neck; there were no cases of contralateral neck recurrence. The 5-year actuarial disease-free survival rates were 82% for the "observation" group and 68% for the elective neck dissection group. This difference was not statistically significant (P = .182). The 5-year actuarial disease-free survival rates were 83% for the "observation" group when those patients who underwent radiotherapy were excluded (n = 22) and 68% for the elective supraomohyoid neck dissection group (n = 25), which showed no statistically significant difference (P = .127).
Conclusions: This study showed that ipsilateral elective neck management is indicated for stage I and II SCC of the oral tongue. On the other hand, our series suggests that contralateral occult lymph node metastasis was unlikely in early-stage oral tongue SCC, and that there was no survival benefit for patients who underwent elective neck dissection in place of observation. Thus, it may not harmful to observe the contralateral N0 neck in the treatment of early oral tongue cancer.
Similar articles
-
Management of contralateral N0 neck in pyriform sinus carcinoma.Laryngoscope. 2006 Jul;116(7):1268-72. doi: 10.1097/01.mlg.0000225936.88411.71. Laryngoscope. 2006. PMID: 16826073
-
Distributions of cervical lymph node metastases in oropharyngeal carcinoma: therapeutic implications for the N0 neck.Laryngoscope. 2006 Jul;116(7):1148-52. doi: 10.1097/01.mlg.0000217543.40027.1d. Laryngoscope. 2006. PMID: 16826050
-
[Squamous-cell carcinoma of the tongue: treatment results and prognosis].Rev Stomatol Chir Maxillofac. 2003 Feb;104(1):10-7. Rev Stomatol Chir Maxillofac. 2003. PMID: 12644785 French.
-
Selective neck dissection (IIA, III): a rational replacement for complete functional neck dissection in patients with N0 supraglottic and glottic squamous carcinoma.Laryngoscope. 2008 Apr;118(4):676-9. doi: 10.1097/MLG.0b013e31815f6f25. Laryngoscope. 2008. PMID: 18182969 Review.
-
Elective supraomohyoid neck dissection for oral cavity squamous cell carcinoma: is dissection of sublevel IIB necessary?Oral Oncol. 2008 Mar;44(3):216-9. doi: 10.1016/j.oraloncology.2007.06.006. Epub 2007 Sep 7. Oral Oncol. 2008. PMID: 17826302 Review.
Cited by
-
Differentiation of benign and malignant lesions of the tongue by using diffusion-weighted MRI at 3.0 T.Dentomaxillofac Radiol. 2015;44(7):20140325. doi: 10.1259/dmfr.20140325. Epub 2015 Mar 31. Dentomaxillofac Radiol. 2015. PMID: 25823772 Free PMC article.
-
CD147 expression correlates with lymph node metastasis in T1-T2 squamous cell carcinoma of the tongue.Oncol Lett. 2017 Oct;14(4):4670-4676. doi: 10.3892/ol.2017.6808. Epub 2017 Aug 24. Oncol Lett. 2017. PMID: 29085466 Free PMC article.
-
Clinicopathological Risk Factors for Contralateral Lymph Node Metastases in Intraoral Squamous Cell Carcinoma: A Study of 331 Cases.Curr Oncol. 2021 May 14;28(3):1886-1898. doi: 10.3390/curroncol28030175. Curr Oncol. 2021. PMID: 34069011 Free PMC article.
-
Prognostic factors of recurrence and neck metastasis in oral carcinomas.Pak J Med Sci. 2016 Nov-Dec;32(6):1553-1556. doi: 10.12669/pjms.326.10661. Pak J Med Sci. 2016. PMID: 28083063 Free PMC article.
-
Evidence-based guideline diagnosis, treatment, prevention and aftercare of oropharyngeal and hypopharyngeal carcinoma.Ger Med Sci. 2025 Jun 24;23:Doc03. doi: 10.3205/000339. eCollection 2025. Ger Med Sci. 2025. PMID: 40655928 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials